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Abstract
In vivo leukocyte recruitment is not fully understood and may result from interactions of chemokines with
glycosaminoglycans/GAGs. We previously showed that chlorite-oxidized oxyamylose/COAM binds the neutrophil
chemokine GCP-2/CXCL6. Here, mouse chemokine binding by COAM was studied systematically and binding affinities of
chemokines to COAM versus GAGs were compared. COAM and heparan sulphate bound the mouse CXC chemokines KC/
CXCL1, MIP-2/CXCL2, IP-10/CXCL10 and I-TAC/CXCL11 and the CC chemokine RANTES/CCL5 with affinities in the nanomolar
range, whereas no binding interactions were observed for mouse MCP-1/CCL2, MIP-1a/CCL3 and MIP-1b/CCL4. The affinities
of COAM-interacting chemokines were similar to or higher than those observed for heparan sulphate. Although COAM did
not display chemotactic activity by itself, its co-administration with mouse GCP-2/CXCL6 and MIP-2/CXCL2 or its binding of
endogenous chemokines resulted in fast and cooperative peritoneal neutrophil recruitment and in extravasation into the
cremaster muscle in vivo. These local GAG mimetic features by COAM within tissues superseded systemic effects and were
sufficient and applicable to reduce LPS-induced liver-specific neutrophil recruitment and activation. COAM mimics
glycosaminoglycans and is a nontoxic probe for the study of leukocyte recruitment and inflammation in vivo.
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Introduction
Chemokines are established central players in coordinating
directional and selective leukocyte migration into tissues for
immune regulation in physiology and pathologies, including
inflammatory disorders, infection and cancer. These chemotactic
cytokines have emerged to constitute a large family of over 50
different members, all of which are characterized by their small
sizes (,8 to 10 kDa) and related structures [1,2]. Accordingly,
chemokines are segregated into C, CC, CXC and CX3C
subfamilies, based on the arrangement of conserved NH2-terminal
cysteine motifs [3]. For most chemokines a further biological
distinction can be made between homeostatic or constitutively
expressed chemokines, and inflammatory or inducible chemo-
kines. The latter subclass is expressed by non-immune and
immune cells upon induction by various stimuli, including
cytokines, such as IL-1b, TNF-a and IFN-c, and microbial-
derived molecular patterns [4]. Among inflammatory chemokines
the ELR+ CXC chemokines carry an NH2-terminal conserved
ELR (Glu-Leu-Arg) motif preceding the first cysteine amino acid
residue, important in receptor interactions. These ELR+ CXC
chemokines are predominantly responsible for neutrophil chemo-
taxis, which is initiated through binding of the G protein-coupled
seven-transmembrane domain receptors CXCR1 and/or
CXCR2, and also possess angiogenic features [5,6]. Examples of
ELR+ CXC chemokines are human IL-8/CXCL8, described as
the most powerful chemoattractant for human neutrophils, and
murine ‘‘granulocyte chemotactic protein-2’’ (GCP-2)/CXCL6,
‘‘keratinocyte-derived chemokine’’ (KC)/CXCL1 ‘‘and macro-
phage inflammatory protein-2’’ (MIP-2)/CXCL2 as potent
neutrophil chemokines in the mouse [7]. On the contrary, CXC
chemokines that lack the ELR motif, such as ‘‘monokine induced
by IFN-c’’ (MIG)/CXCL9, ‘‘IFN-c-inducible protein of 10 kDa’’
(IP-10)/CXCL10 and ‘‘IFN-inducible T cell a chemoattractant’’
(I-TAC)/CXCL11, are predominantly chemotactic toward acti-
vated T lymphocytes, NK cells and monocytes, and additionally
contain angiostatic properties [6]. CC chemokines, including
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‘‘monocyte chemotactic protein-1’’ (MCP-1)/CCL2, ‘‘macro-
phage inflammatory protein-1a’’ (MIP-1a)/CCL3 and ‘‘regulated
upon activation, normal T cell expressed and secreted’’
(RANTES)/CCL5 are predominantly chemotactic for monocytes,
NK cells, dendritic cells and activated T cells [1,2]. Furthermore,
chemokines tend to synergize directly or indirectly with other
chemokines, cytokines, inflammatory mediators or pathogen-
derived molecules, thereby providing a powerful mechanism to
strengthen leukocyte recruitment [8–10].
Besides mediating their biological effects by binding to
chemokine receptors, another interaction of chemokines implicates
binding to linear sulphated glycosaminoglycan chains (GAGs),
including heparan-, dermatan- and chondroitin sulphates and
heparin. Leukocyte recruitment into tissues is supposed to require
chemokine presentation on endothelial cells to circulating immune
cells, as well as the establishment of a sustained chemotactic
gradient across the vessel walls and into the extracellular matrix
and tissues. GAGs are crucial molecules throughout this process by
locally restraining chemokines, preventing chemokine dilution and
even protection against proteolysis [11,12]. Indeed, heparan
sulphate has been shown to immobilize chemokines at the luminal
endothelial cell surface [13]. In particular, sequestering of MIP-2/
CXCL2 on endothelial cells through heparan sulphate binding is
essential to establish intraluminal crawling and endothelial
transmigration of neutrophils [14]. However, additional tools are
needed to study chemotaxis in vivo and to evaluate whether and
how interference with chemotaxis may be possible, beneficial or
detrimental.
Recently, we have described a polyanionic polysaccharide
derivative, designated COAM (for chlorite-oxidized oxyamylose),
as an immunomodulator with antiviral activity [15,16]. When
injected intraperitoneally (i.p.), COAM induces the recruitment of
neutrophils and macrophages that are in part essential to control
viral burden and mortality upon acute infection with a neurotropic
virus [16]. This effect of COAM, mediated by binding of GCP-2/
CXCL6, illustrates that neutrophils contribute to antiviral
resistance by the host, and can be further exploited to combat
acute neuroinflammation [17], and cancer [18].
The negative charges and linear structure, together with the
binding characteristics for GCP-2/CXCL6, provide COAM with
features resembling natural GAGs. In fact, COAM possesses
higher affinities to mouse GCP-2/CXCL6 than heparan sulphate
and chondroitin sulphate [16]. This fact incites systematic
investigations about local and general effects of COAM on
leukocytes. For instance, it is not known whether and which other
chemokines than GCP-2/CXCL6 interact with COAM, whether
this interaction is different from that with heparan sulphate and
what these findings clarify about the biological effects of COAM
in vivo.
Here, we compared the binding of various mouse chemokines to
COAM and heparan sulphate, a prototypic GAG. We showed
that COAM had the ability to bind specifically to chemokines with
kinetics similar to or higher than those for heparan sulphate. This
information suggested that COAM might compete with GAGs for
selective chemokine binding. The chemokine binding feature of
COAM was translated to in vivo local recruitment of leukocytes,
as COAM synergized with GCP-2/CXCL6, MIP-2/CXCL2 and
endogenous chemokines for recruitment of neutrophils in different
animal models of local application. In addition, this formed the
basis to use COAM-induced chemotaxis and to test its effects on
systemic neutrophil recruitment. We thus established that COAM
is a critical probe to study cell recruitment in vivo.
Materials and Methods
Reagents
COAM was synthesized by a two-step oxidation of amylose,
purified and fractionated according to molecular weight (MW) as
described previously [15,19]. COAM was endotoxin-free and
either used as a MW mixture or as high MW fractions
(corresponding to protein molecular equivalent weights exceeding
100 kDa). Poly(I:C) and heparan sulphate were purchased from
Sigma-Aldrich (St. Louis, MO). Because many heparan sulphate
preparations are heterogeneous and may vary from batch to
batch, we used a heparan sulphate preparation with similar
molecular characteristics as COAM, as detailed previously [18]. In
addition, previously we also compared COAM with other
glycosaminoglycans, including chondroitin sulphate and heparan
sulphate preparations for binding to GCP-2/CXCL6 and
demonstrated higher affinities for COAM than for both glycos-
aminoglycans [16]. Recombinant mouse chemokines were ob-
tained from Peprotech (Londen, UK).
Mice
Animal experiments at the Rega Institute for Medical Research,
University of Leuven, were carried out with female adult NMRI
mice purchased from Elevage Janvier (Le Genest Saint Isle,
France), in agreement with the Ethical Committee for Animal
Care and Use of the KU Leuven (License number for Belgium
LA1210243) and with adherence to international guidelines for
animal ethics and welfare. Mouse studies at the University of
Uppsala were performed in adult C57BL/6 male mice purchased
from Taconic (M&B, Ry, Denmark) and housed in the local
animal facility under standardized conditions of temperature (21–
22uC) and illumination (12 h light/12 h darkness) with free access
to tap water and pelleted food (Type R36, Lantma¨nnen, Kimstad,
Sweden). The experiments were approved by the Regional Animal
Ethics Committee in Uppsala, Sweden. For the intravital
microscopy studies, male C57Bl/6J mice were purchased from
Jackson Laboratories (Bar Harbor, ME). Animals were maintained
in a specific pathogen-free environment at the University of
Calgary Animal Resource Centre. All experimental animal
protocols were approved by the University of Calgary Animal
Care Committee and were in compliance with the Canadian
Council for Animal Care Guidelines.
Surface plasmon resonance (SPR)
Binding kinetics of chemokines to COAM and heparan sulphate
were determined by surface plasmon resonance (SPR) analysis on
a Biacore T200 instrument (GE Healthcare, Uppsala, Sweden).
COAM was fractionated by gel filtration chromatography on
Superdex S-200 (GE Healthcare) [15] and high MW COAM was
biotinylated, as follows. COAM and heparan sulphate were
dissolved at 2 mg/ml in 0.15 M sodium chloride, 0.1 M sodium
phosphate pH 7.5. Biotinamidohexanoic acid hydrazide (Sigma-
Aldrich) at a final concentration of 5 mM was reacted with
COAM for 2 h at room temperature. Excess reactant was
removed by gel filtration on a 10 ml Sephadex G-25 column
equilibrated with PBS [20]. Biotinylated high MW COAM and
heparan sulphate were immobilized on a streptavidin (SA)-coated
biosensor chip (GE Healthcare). A reference flow cell was used as a
control for non-specific binding and refractive index changes. All
interaction studies were performed at 25uC. The tested chemo-
kines were serially diluted in HBS-P (10 mM HEPES, 150 mM
NaCl and 0.05% surfactant P20; pH 7.4) using two-fold dilution
steps. Samples were injected for 2 min at a flow rate of 45 ml/min
and dissociation was followed for 5 min. Several buffer blanks
COAM Binds Chemokines in the Mouse
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were used as double referencing controls. Regeneration of the SA
sensor chip surface was performed with a 1 second pulse of
50 mM NaOH. Experimental data were fit by using the 1:1
binding model with mass transfer correction (Biacore T200
Evaluation software 1.0) to determine the binding kinetics.
Affinities (KD) were estimated from the ratio of dissociation (koff)
and association (kon) rate constants.
Figure 1. Binding of mouse chemokines to COAM and heparan sulphate. Concentration ranges from 200 nM to 0 nM of mouse (A) GCP-29–78,
(B) KC/CXCL1, (C) MIP-2/CXCL2, (D) IP-10/CXCL10, (E) I-TAC/CXCL11 and (F) RANTES/CCL5 was run over SA sensor chips surfaces onto which biotinylated
COAM and heparan sulphate (HepS) were immobilized. Binding was measured by SPR technology and the resulting experimental sensorgrams are shown
in gray. For curve fitting, shown as black lines, the following concentrations were used in two-fold dilution series: 50–6.25 nM for GCP-29–78, 25–3.13 nM
for KC/CXCL1, 200–25 nM for MIP-2/CXCL2, 6.25–0.78 nM for IP-10/CXCL10, 50–6.25 nM for I-TAC/CXCL11 and 400–50 nM for RANTES/CCL5.
doi:10.1371/journal.pone.0104107.g001
Table 1. Kinetic parameters resulting from SPR analysis with COAM and heparan sulphate versus different mouse chemokines.
COAM Heparan sulphate
Chemokine kon (1/M.s) koff (1/s) KD (nM) kon (1/M.s) koff (1/s) KD (nM)
KC/CXCL1 (1.4960.92) E+06 (1.9061.06) E202 13.161.0 (1.5760.02) E+06 (1.9160.13) E202 12.160.7
MIP-2/CXCL2 (1.2161.02) E+07 (2.2461.53) E201 20.764.9 (5.9661.91) E+04 (4.5261.12) E203 78.0615.6
GCP-2/CXCL6 (8.7364.77) E+06 (8.2460.23) E203 1.160.6 (9.0962.00) E+04 (8.6161.37) E203 95.366.1
MIG/CXCL9 N.D. N.D. N.D. N.D. N.D. N.D.
IP-10/CXCL10 (1.2860.19) E+06 (5.2761.83) E204 0.4160.08 (4.4461.49) E+06 (4.2261.38) E203 0.9560.08
I-TAC/CXCL11 (4.9060.38) E+06 (7.4960.04) E202 15.361.1 (5.0861.07) E+05 (5.7361.44) E202 118.3653.3
MCP-1/CCL2 N.B. N.B. N.B. N.B. N.B. N.B.
MIP-1a/CCL3 N.B. N.B. N.B. N.B. N.B. N.B.
MIP-1b/CCL4 N.B. N.B. N.B. N.B. N.B. N.B.
RANTES/CCL5 (1.3661.19) E+03 (1.0960.24) E203 530684 (5.3161.88) E+03 (9.1061.23) E204 180634
kon association rate constant expressed in M
21 s21; koff dissociation rate constant expressed in s
21; KD dissociation equilibrium (affinity) constant resulting from the ratio
of koff and kon, expressed in nM.
N.B. No binding signals were observed.
N.D. Kinetic parameters could not be determined.
Values represent means of two independent experiments 6 standard deviations.
doi:10.1371/journal.pone.0104107.t001
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Leukocyte recruitment into the peritoneal cavity
NMRI mice were i.p. injected with 1 mg COAM (high MW;
200 ml) or 100 ng mouse GCP-2(9–78) (200 ml), or with a solution of
premixed COAM and mouse GCP-2(9–78), all diluted in sterile
endotoxin-free PBS. At various time points after injection,
peritoneal cells were collected by washing the peritoneal cavity
with 5 ml PBS containing 2% FBS. Total cell numbers from these
lavage fluids were determined and single cell suspensions
containing 0.56106 cells were stained with FITC-conjugated
anti-Ly6G mAb (clone 1A8) and APC-conjugated anti-CD11b
mAb (eBioscience, San Diego, CA) for the presence of neutrophils.
Samples were analyzed with a FACSCalibur flow cytometer (BD
Biosciences Immunocytometry Systems, San Jose, CA) by using
CellQuest software. Absolute cell numbers were calculated by
multiplying the obtained cell percentages with total peritoneal cell
counts.
In vivo neutrophil recruitment into the cremaster muscle
Male C57Bl/6 mice of similar age were injected with an
intrascrotal injection of 200 ml with either saline (sterile NaCl) or
COAM (0.2 mg) 3 or 24 h prior to experiments. At the time for
experiment, mice were anaesthetized by spontaneous inhalation of
isoflurane gas (Forene, Abbott Scandinavia AB, Stockholm,
Sweden) via an isoflurane pump (Univentor 400 Anesthesia Unit,
AgnTho’s AB, Lidingo¨, Sweden) through a breathing mask
containing a mixture of air and oxygen (total oxygen 40%) and
,2.4% isoflurane. The animals were placed on a water-heated
operating table to maintain body temperature at ,37uC. The
depth of anesthesia was controlled by regularly monitoring
peripheral reflexes. The cremaster muscle was prepared as
previously described [21,22]. Briefly, the muscle was dissected
free from other tissues and opened longitudinally with cautery.
The muscle was held flat on a cover slip by attaching five sutures
in the corner of the tissue and the tissue was then constantly
Figure 2. In vivo recruitment of neutrophils into the peritoneal cavity. Mice received an i.p. dose of 1 mg of purified high MW COAM, or
100 ng mouse GCP-2(7–98), or a mixture of both COAM (1 mg) and mouse GCP-2(7–98) (100 ng). After 1 h (A) or 4 h post-treatment (B), peritoneal
lavage fluids were collected and the percentages and absolute numbers of neutrophils, recognized as CD11b and Ly6G double positive cells,
determined by FACS analysis, are shown. The net numbers of CD11b+ Ly6G+ cells were determined by multiplying the percentages of CD11b+ Ly6G+
cells with total peritoneal leukocyte counts. Histograms and dots represent group medians and spreading of individual data points from each mouse,
respectively. *P,0.05, **P,0.01, ***P,0.001, as determined by Kruskal-Wallis test.
doi:10.1371/journal.pone.0104107.g002
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superperfused (1 ml/min) with pre-warmed bicarbonate buffered
saline (pH 7.4), throughout the experiment. After a resting period
of 30 min, a cremasteric venule with a diameter of ,25–35 mm
was selected and its blood flow was recorded during a 5-minute-
period through an intravital microscope (Leica Microsystems
DM5000B, Wetzlar, Germany) with a CCD camera (Hamamatsu
Orca-R2, Hamamatsu City, Japan) connected to a computer with
Volocity 5.0 Acquisition software. After the first recording period,
a low dose (0.5 nmol/l) of the chemokine macrophage inflamma-
tory protein-2 (MIP-2/CXCL2; R&D Systems, Abingdon, UK)
was added to the superperfusate in some of the groups throughout
the remaining experiment. MIP-2 binds to the receptor CXCR2
and has previously been shown to recruit predominantly
neutrophils [21], and the low dose of this chemokine was chosen
Figure 3. In vivo recruitment of neutrophils to the cremaster muscle. Mice received an intrascrotal dose of 0.2 mg of purified high MW
COAM, or saline at 3 (A and B) or 24 (C and D) h prior to induction of anesthesia, surgical preparation of the cremaster muscle and onset of MIP-2/
CXCL2 superperfusion. The number of adherent neutrophils (A and C) were quantified within a 100 mm length of venule, and the number of
emigrated neutrophils within the field of view (B and D) were quantified prior to or following 30, 60 and 90 min of MIP-2/CXCL2 superperfusion. *P,
0.05, **P,0.01, ***P,0.001, as determined by students’ t-test.
doi:10.1371/journal.pone.0104107.g003
Table 2. Effect of MIP-2/CXCL2 superperfusion of the cremaster muscle on number of rolling neutrophils (cells/min).
Time following MIP-2/CXCL2
addition to the superperfusate 30 min 60 min 90 min
Saline 3 h 5664 4263 3763
COAM 3 h 3767 2967 2164
Saline 24 h 3065 2464 1763
COAM 24 h 5367* 4365* 3867*
*Numbers represent means 6 SEM. *Indicates p,0.05 versus saline control.
doi:10.1371/journal.pone.0104107.t002
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to clearly reveal a possible COAM-potentiating effect on numbers
of recruited neutrophils. Periods of five minutes were recorded at
30, 60 and 90 min after MIP-2 addition. The number of rolling
leukocytes was counted during each of these 5 min periods and an
average of rolling neutrophils per min was calculated. The rolling
cell velocity of the first ten rolling cells during each period was
measured. Also, the number of adherent neutrophils in a 100 mm
long segment of the venule, as well as the number of emigrated
cells in the field of view (FOV) (200 mm6300 mm, 0.06 mm2) was
analyzed. The cremaster muscles were saved for further analyses.
Preparation of the mouse liver for intravital microscopy
Mice received an i.p. injection of 1 mg/kg LPS 4 hr prior to
intravital microscopy. Alternatively, some animals received an
injection of LPS (1 mg/kg) and COAM (2 mg/mouse). Mice were
anesthetized with a mixture of ketamine hydrochloride (200 mg/
kg, Rogar/SBT) and xylazine hydrochloride (10 mg/kg, MTC
Pharmaceuticals). After anesthesia, cannulation of the right jugular
vein was performed for administration of additional anesthetic and
for injection of antibodies or other reagents. Preparation for
intravital imaging of the liver was performed as previously
described [23]. Briefly, a midline incision followed by a lateral
incision along the costal margin to the midaxillary line was
performed to expose the liver. The mouse was placed in a right
lateral position, and ligaments attaching the liver to the diaphragm
and the stomach were cut, thus allowing the liver to be
externalized onto a glass coverslip located on the inverted
microscope heat-controlled stage. Exposed abdominal tissues were
covered with saline-soaked gauze to prevent dehydration. The
liver was draped with a saline-soaked tissue paper to avoid tissue
dehydration and to help restrict movement of the tissue on the
slide.
Spinning disk confocal intravital microscopy
The exposed liver lobe was visualized with an Olympus IX81
inverted microscope equipped with a confocal light path (Wave-
Fx; Quorum) based on a modified Yokogawa CSU-X1 head
(Yokogawa Electric Corporation) with a UPLANSAPO 106/0.40
or UPLANSAPO 206/0.70 air objective. Four laser excitation
wavelengths (491, 561, 643, and 730 nm; Cobalt) were used in
rapid succession and visualized with the appropriate long-pass
filters (Semrock). Exposure times for excitation wavelengths were
400 ms for all lasers. A back-thinned EMCCD 5126512 pixel
camera (C9100–13, Hamamatsu, Bridgewater, NJ) was used for
fluorescence detection. Volocity acquisition software (Improvision)
was used to drive the microscope.
Analysis of spinning disk confocal microscope-acquired
images
Fluorescence imaging of neutrophil counts and NET compo-
nents was performed with intravital immunofluorescence analysis.
Neutrophils were visualized by injection of Alexa-fluor 750-anti-
mouse Ly6G antibody (3 mg). Extracellular DNA was labeled with
Sytox Green DNA dye (5 mM), histone H2Ax was labeled with
Alexa-fluor 555-anti-mouse H2Ax antibody (5 mg), and neutrophil
elastase (NE) was labeled with Alexa-fluor 647-anti-mouse NE
antibody (0.6 mg). All antibodies and dyes were injected i.v.
15 min prior to intravital imaging. Neutrophils and NETs were
quantified with SD-IVM using previously published methodology
[23]. In brief, images were acquired as z stacks of xy planes (1 mm
intervals) from the bottom to top of sinusoids in each field of view
using a 206 objective lens, and saved as extended focus images
in.tiff format. Images from individual color channels (e.g., red for
histone H2Ax, far red for elastase) were exported and analyzed in
ImageJ (NIH). Neutrophils were counted per 106FOV, minimum
4 FOV from each mouse. Intensity of histone and elastase staining
was analyzed so that differences in background fluorescence
between experiments and antibody lots could be accounted for
Table 3. Effect of MIP-2/CXCL2 superperfusion on rolling neutrophil velocity (mm/s) in the cremaster muscle.
Time following MIP-2/CXCL2
addition to the superperfusate 30 min 60 min 90 min
Saline 3 h 2566 2564 3364
COAM 3 h 3267 2964 2863
Saline 24 h 1765 2065 2267
COAM 24 h 2665 2965 3366
*Numbers represent means 6 SEM.
doi:10.1371/journal.pone.0104107.t003
Table 4. Numbers of neutrophil-endothelial cell interactions observed 30 min following surgical preparation of the cremaster
muscle after 3 h pretreatment with saline or COAM.
Saline treated mice COAM treated mice
Number of rolling cells (cells/min) 6468 4165
Rolling cell velocity (mm/s) 1963 2165
Number of adherent cells (cells/min) 562 661
Number of emigrated cells
(cells/field of view)
662 661
*Numbers represent means 6 SEM.
doi:10.1371/journal.pone.0104107.t004
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and background autofluorescence could be eliminated. Contrast
was adjusted to minimize autofluorescent background staining,
and a minimum brightness threshold was set to yield only positive
staining. The same contrast and threshold values were applied to
all images from all treatment groups within the experiment.
Thresholded images were converted to binary (black and white),
and the area per field of view covered by positive fluorescence
staining (black) was calculated with ImageJ software. Data were
expressed as the percentage of area in each FOV covered by
positive fluorescence staining.
Statistical analysis
Statistical analyses were performed using Prism 5 (GraphPad
Software, San Diego, CA) or SigmaStat 3.5 (Systat Software,
Richmond, VA). Differences between treatment and control
groups were evaluated using the nonparametric Mann-Whitney
U test for comparing two groups, or the Kruskal-Wallis test for
comparing three or more groups. For the in vivo neutrophil
recruitment experiments, one way repeated measurements of
ANOVA was used when comparing the same animal at different
time points with Dunnett’s post hoc test and student’s t-test was
used for comparing two groups. P values,0.05 were considered
statistically significant.
Results
Mouse CXC and CC chemokines bind to COAM and
heparan sulphate
Several chemokines have already been shown to bind with
varying affinities to glycosaminoglycans (GAGs), including heparan
sulphate. These interactions and their selectivities co-determine
chemokine function and regulation [11]. Previously, we showed that
COAM binds to mouse GCP-2/CXCL6 with higher affinity than
heparan sulphate and chondroitin sulphate and that the resulting
in vivo recruitment of neutrophils partially explains host antiviral
resistance. Because neutrophil depletion did not completely wipe
out the antiviral effect [16], we hypothesized that other leukocyte
types and, hence, other chemokines might be involved. We here
investigated systematically whether COAM displays GAG-mimetic
functions, by measuring interactions of various mouse chemokines
with COAM and comparing these with heparan sulphate, using
SPR technology. We used COAM- and also heparan sulphate-
mediated binding of the mouse neutrophil chemoattractant GCP-
2/CXCL6, as illustrated in Fig. 1A as a reference experiment [16].
A truncated form of mouse GCP-2/CXCL6, GCP-2(9–78), was used
as the reference, as this processed form results in a marked
potentiation of neutrophil chemotaxis compared with the intact
form, both in vitro and in vivo [24]. Decreasing concentrations
(two-fold dilutions, starting from 200 nM) of soluble recombinant
GCP-2(9–78) resulted in a concentration-dependent binding inter-
action between GCP-2(9–78) and immobilized COAM and heparan
sulphate. Next, the binding of other chemokines to COAM was
specified. Two other mouse ELR+ CXC chemokines, KC/CXCL1
and MIP-2/CXCL2, and the mouse ELR2 CXC chemokines IP-
10/CXCL10 and I-TAC/CXCL11 efficiently bound to both
COAM and heparan sulphate in a concentration-dependent
manner (Fig. 1B–E). Due to non-specific binding interaction with
the reference flow channel, binding of the mouse ELR2 CXC
chemokine MIG/CXCL9 resulted in abnormal binding curves for
COAM and heparan sulphate (data not shown). Of the four mouse
CC chemokines (MCP-1/CCL2, MIP-1a/CCL3, MIP-1b/CCL4,
RANTES/CCL5) that were tested, only RANTES/CCL5 dis-
played binding interactions with COAM and heparan sulphate
(Fig. 1F), whereas MCP-1/CCL2, MIP-1a/CCL3 and MIP-1b/
CCL4 were found not to bind to either COAM or heparan sulphate
even at the highest concentration tested (400 nM) (data not shown).
Figure 4. Effects of COAM co-treatment on LPS-induced systemic inflammation in the liver. (A) Co-application of COAM (2 mg/mouse)
with intraperitoneally administrated LPS (1 mg/kg) decreases neutrophil infiltration to the liver at 4 h of inflammation; (B) representative images of
neutrophils present in the liver sinusoids of LPS- and LPS plus COAM-treated mice (green cells – autofluorescent hepatocytes; 20x; scale bars
represent 50 mm). Quantification of extracellular neutrophil elastase (C) and histone (D) within the livers of LPS and LPS+COAM-treated animals (mean
area of staining per 206FOV 6 SD; scale bars represent 45 mm). Intravital visualization of NET deposition in the liver vasculature of LPS-treated and
LPS plus COAM-treated mice (E). Staining for extracellular neutrophil elastase (NE) and histone illustrates clear deposition of these characteristic
molecules of NETs in the liver after either treatment. In addition, overlay of histone and elastase staining is shown. Staining for extracellular DNA is
presented with a higher magnification to clearly picture Sytox green deposition along the liver sinusoids; areas of the extDNA deposition are marked
with red arrows. Neutrophil, elastase and histones were measured in five FOV/mouse, n = 5–7 animals per group; *P,0.05.
doi:10.1371/journal.pone.0104107.g004
Table 5. Theoretical isoelectric points and carboxyterminal amino acid sequences of mouse chemokines.
Mouse chemokine Isoelectric point (theoretical) COOH-terminal amino acid sequence Pubmed entry number
MIG (CXCL9) 10.62 - KQKRGKKHQKNMKNRKPKTPQSRRRSRKTT P18340
I-TAC (CXCL11) 10.11 - RQRCLDPRSKQARLIMQAIEKKNFLRRQNM Q9JHH5
IP-10 (CXCL10) 10.05 - NDEQRCLNPESKTIKNLMKAFSQKRSKRAP P17515
MCP-1 (CCL2) 9.81 - LTRKSEANASTTFSTTTSSTSVGVTSVTVN P10148
MIP-2 (CXCL2) 9.30 - LKGGQKVCLDPEAPLVQKIIQKILNKGKAN P10889
GCP-29–78 (CXCL6) 9.21 - KNQKEVCLDPEAPVIKKIIQKILGSDKKKA P50228
KC (CXCL1) 9.10 - TLKNGREACLDPEAPLVQKIVQKMLKGVPK P12850
RANTES (CCL5) 8.76 - VVFVTRRNRQVCANPEKKWVQEYINYLEMS P30882
MIP-1b (CCL4) 5.64 - VVFLTKRGRQICANPSEPWVTEYMSDLELN P14097
MIP-1a (CCL3) 5.14 - IFLTKRNRQICADSKETWVQEYITDLELNA P10855
Basic amino acids (arginine, R; lysine, K) are underlined.
doi:10.1371/journal.pone.0104107.t005
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Since the CC chemokines MCP-1/CCL2, MIP-1a/CCL3 and
MIP-1b/CCL4 did not bind, whereas RANTES/CCL5 did, we
deduced that selectivity existed in chemokine binding to both
COAM and heparan sulphate. As previously shown for the binding
of GCP-2/CXCL6 to heparan sulphate and chondroitin sulphate,
the binding intensity for specific chemokines differed considerably
between COAM and heparin sulphate (vide infra).
Kinetic analysis of the interaction between mouse
chemokines and COAM or heparan sulphate
Examination of the obtained sensorgrams suggested different
binding characteristics between different mouse chemokines for
the same compound and also between the two compounds for the
same chemokine. Association and dissociation phases were
measured and the resulting sensorgrams were used for calculating
kinetic parameters to characterize the nature of the binding
interactions (Table 1). For KC/CXCL1, both the association (kon)
and dissociation (koff) rates were comparable between COAM and
heparan sulphate, which resulted in corresponding mean affinity
KD values of 13.161.0 nM and 12.160.7 nM, respectively. MIP-
2/CXCL2 displayed a fast association and dissociation rate
towards COAM, whereas binding to heparan sulphate was
characterized by a 2.3 log slower association and a 1.7 log slower
dissociation. This resulted in a.3-fold stronger affinity of MIP-2/
CXCL2 toward COAM (KD=20.764.9 nM) compared to
heparan sulphate (KD= 78.0615.6 nM). Moreover, the sensor-
grams for MIP-2/CXCL2 showed a biphasic response, i.e. an
initial rapid association and dissociation rate were followed by a
reduction of these rates. GCP-2/CXCL6 displayed a tight affinity
toward COAM (KD=1.160.6 nM) and a 2-log difference in
association rates resulted in a 86.6 fold weaker affinity toward
heparan sulphate (KD=95.366.1 nM). Also I-TAC/CXCL11
showed a 7.7-fold tighter affinity for COAM (KD=15.361.1 nM)
in comparison to heparan sulphate (KD=118.3653.3 nM). Of all
chemokines tested, IP-10/CXCL10 showed the strongest affinity
for COAM and heparan sulphate with comparable mean KD
values of 0.4160.08 nM and 0.9560.08 nM, respectively. The
10-fold difference between the koff values resulted in a faster
dissociation rate for heparan sulphate compared to COAM. The
mouse CC chemokine RANTES/CCL5 showed the weakest
binding affinity for COAM and heparan sulphate, with a 3-fold
stronger binding to heparan sulphate compared to COAM.
Together, these results indicated that COAM mimics glycosami-
noglycans by binding to chemokines, the interaction of which is
characterized by high affinity in the nanomolar KD range. We
were able to order the KD values for COAM as follows, from high
to low affinity: IP-10/CXCL10. GCP-2/CXCL6. KC/
CXCL1. I-TAC/CXCL11. MIP-2/CXCL2. RANTES/
CCL5. For heparan sulphate affinity, these chemokines were
ranged in the following order: IP-10/CXCL10. KC/CXCL1.
MIP-2/CXCL2. GCP-2/CXCL6. I-TAC/CXCL11.
RANTES/CCL5. This comparison indicated that the interactions
between chemokines and COAM versus heparan sulphate were
different.
COAM-anchored mouse GCP-2/CXCL6 potentiates fast
in vivo neutrophil migration
The interaction site of chemokines with their receptors is
located at the chemokine aminoterminus, whereas chemokine
binding to glycosaminoglycans is less well understood [11,12]. If
the binding of COAM would interfere with the chemokine
receptor interaction, COAM should reduce chemotaxis. With the
observation that COAM is a potent chemokine-binding molecule,
we investigated whether this binding effect might potentiate the
chemotaxis of leukocytes or rather inhibit this effect by blocking
the chemokine aminoterminus. To this end, we studied the
infiltration of neutrophils into the peritoneal cavity of mice
following injection of mouse GCP-2(9–78), alone or together with
COAM. Intraperitoneal injection of COAM did not significantly
change, within 1 h, the percentage and absolute numbers of
recruited CD11b+ Ly6G+ cells, designated as being neutrophils
(Fig. 2A). The percentage and absolute numbers of neutrophils
slightly increased after 1 h upon injection of 100 ng GCP-2(9–78).
Moreover, a simultaneous injection of premixed COAM (1 mg)
and GCP-2(9–78) (100 ng) potentiated the chemotaxis of neutro-
phils toward the peritoneal cavity. Indeed, COAM-associated
GCP-2(9–78) significantly increased the percentages of infiltrated
neutrophils as well as the net neutrophil numbers, when compared
to the control group and to mice that received only GCP-2(9–78).
Furthermore, when analyzed after 4 h, a completely different
picture emerged. Both the percentages as well as the net numbers
of peritoneal neutrophils were significantly increased by COAM
and no further potentiation of neutrophil chemotaxis was observed
for GCP-2(9–78) (Fig. 2B). This illustrated that the binding
interactions of COAM with chemokines, observed in vitro, [16
and Fig. 1] can be translated to in vivo leukocyte migration, as the
combination of COAM with GCP-2/CXCL6 potentiated the
recruitment of neutrophils. These results suggested that COAM
might mimic GAG functions, also in vivo, by interactions with
(endogenous) chemokines that enhanced the migration of leuko-
cytes at 4 h. Furthermore, this was in line with the idea that
COAM binds to GCP-2/CXCL6 in a manner without interfering
with the aminoterminal receptor-binding domain and signaling
capacity of this chemokine. In this way, we could rule out that
COAM inhibits local cell recruitment in vivo at the site of its
injection.
COAM enhances chemokine-induced neutrophil
adhesion and transmigration in vivo
To reinforce the in vivo chemotaxis data, obtained with GCP-
2(9–78), we analyzed the effect of COAM injected intrascrotally
prior to chemokine superperfusion of the cremaster muscle. In this
case we used the neutrophil chemokine MIP-2/CXCL2 that has a
lower affinity for COAM than GCP-2/CXCL6 (Table 1). At
different time intervals (0, 30, 60, 90 min) after MIP-2/CXCL2
addition to the cremaster muscle superperfusate, neutrophil-
endothelial cell interactions were registered through an intravital
microscope, and the number of rolling neutrophils as well as their
velocity (Tables 2 and 3), and the number of adherent (Fig. 3A, C)
and emigrated (Fig. 3B, D) neutrophils were quantified. Pretreat-
ment with COAM for 3 h did not significantly alter basal levels of
neutrophil-endothelial cell interactions when compared to saline
injections (Table 4). With time, following addition of MIP-2/
CXCL2, the number of both adherent and emigrated neutrophils
increased slightly in saline pretreated groups (Fig. 3 A–D).
However, pretreatment with COAM intrascrotally 3 h prior to
the experiment enhanced the chemoattracting ability of MIP-2/
CXCL2 and significantly more neutrophils were adhering and
emigrating compared to the saline treated group receiving MIP-2/
CXCL2 (Fig. 3), while the numbers of rolling cells and their
velocities were not changed (Tables 2 and 3). When COAM was
administered 24 h prior to the experiments, the number of
recruited cells were significantly increased already prior to
addition of MIP-2/CXCL2, suggesting that COAM binds
endogenous chemokines that retain the capacity to induce
neutrophil recruitment from the cremasteric microcirculation
(Fig. 3, Table 2). Following addition of MIP-2/CXCL2 to the
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superperfusate, the number of emigrated neutrophils was further
increased, demonstrating that COAM potentiates transendothelial
emigration to MIP-2/CXCL2. Even with a 20-fold lower affinity
of MIP-2/CXCL2 for COAM, in comparison with GCP-2/
CXCL6, COAM enhanced, rather than diminished, the local
biological effect of MIP-2/CXCL2 on leukocyte recruitment in
this second in vivo animal model.
Intraperitoneal COAM affects neutrophil recruitment and
NET formation in the inflamed liver
Both previously reported in vivo cell recruitment effects of
COAM were studied locally, i.e. at the site of COAM injection.
We next evaluated whether local COAM injection affected
leukocyte counts in a distant organ. Intraperitoneal administration
of LPS (endotoxinemia) leads to neutrophil recruitment to the liver
microvasculature and the release of NETs that protect host cells
from infection, as shown previously [25]. Here we visualized the
liver microvasculature using spinning-disk confocal intravital
microscopy (SD-IVM). In endotoxemic mice, 4 h after the
administration of LPS, we observed 10-fold increased numbers
of accumulated neutrophils (Fig. 4A) (per field 49,0062,864 cells
upon LPS treatment versus 4,0063,61 cell in untreated mice; the
latter group not shown). When COAM was injected in the
peritoneal cavity together with LPS, the recruitment of neutro-
phils, which is known to be massive after ip injection of COAM
[16], was significantly decreased in the liver, in comparison with
the LPS-treatment group. This demonstrates that local injection of
COAM may lead to a systemic effect in the liver (Fig. 4 A, B).
The injection of LPS also induced NET formation in the liver
sinusoids (Fig. 4 C–E). We visualized NETs as structures
composed of the extracellular DNA with attached histones and
neutrophil elastase in vivo. To detect the presence of extracellular
DNA (extDNA) within the liver vasculature, we intravenously
infused the cell-impermeable DNA dye Sytox Green, and to
undoubtedly confirm that these structures are NETs we intrave-
nously applied fluorescently labeled antibodies specific for histone
H2Ax (red) and neutrophil elastase (blue) and demonstrated that
these NET-defining components colocalize (Fig. 4E). NETs, as
revealed by both histone and elastase staining, were observed
stably attached to the vessel walls of the liver (Fig. 4E). When we
quantified the area covered by neutrophil elastase within the liver
sinusoids, we detected a significant difference of 40% between
mice treated with LPS only, and LPS co-administrated together
with COAM. The presence of COAM led to significant decrease
in the elastase staining (Fig. 4C). There was also a tendency to
decreased histone levels (Fig. 4D). We also verified the presence of
extDNA (Fig. 4E bottom) but this parameter was not quantified
due to the fact that hepatocytes are autofluorecently green.
Nevertheless, when comparing the images, there was a clear
difference between the LPS- and LPS plus COAM-treated mice as
in the latter ones less extDNA could be observed (Fig. 4E bottom).
To confirm that Sytox Green specifically stained for extDNA and
was useful to detect the NET-backbone, we intravenously infused
DNase which completely dissolved the green staining along the
liver sinusoids (not shown). In conclusion, these data demonstrated
that intraperitoneal administration of COAM, which itself
generates local recruitment of neutrophils [16], results in general
effects to the extent that this infiltration supersedes the expected
neutrophil migration to the liver as a distant organ.
Discussion
We demonstrated here that COAM is an excellent probe to
study local tissue-specific leukocyte recruitment and its systemic
effects on leukocyte migration in distant organs. Neutrophil
chemotaxis toward the site of COAM injection was originally
associated with the presence of elevated amounts of the ELR+
CXC chemokine GCP-2/CXCL6 and binding to COAM, cell
recruitment and virus destruction [16]. Nothing was known about
effects of COAM on the expression and binding to chemokines,
other than GCP-2/CXCL6. Furthermore, whereas the effects of
COAM on local injection are evident [16,18], COAM may also
exert effects on distant organs [17]. To study distant effects, we
used here an animal model of LPS-induced recruitment of
neutrophils to the liver and local neutrophil extracellular traps
(NET) formation, and imaged in real time immunological events
occurring upon COAM treatment with confocal intravital
microscopy. Whereas intraperitoneal injection of COAM had
the expected local effects on neutrophil recruitment [16], it also
reduced significantly the LPS-induced influx of neutrophils to the
liver as well as the subsequent formation of NETs by these cells.
This illustrates that local COAM injection is so potent that it
generates systemic effects such as decreasing the numbers of
leukocytes in the liver or the central nervous system [17]. In these
distant organs, COAM thus might possess anti-inflammatory
properties. Our studies with three different animal models thus
indicate that COAM is an excellent probe to study also leukocyte
recruitment by endogenous chemokines in vivo.
Another aspect was to evaluate whether other, if not all,
chemokines are affected by COAM as a way to broaden our
understanding of polycarboxylates on leukocyte recruitment
in vivo. It is clear that COAM induced chemokines in cell-specific
ways and bound chemokines with varying affinities. It has
previously been shown that the peritoneal mesothelium and
resident macrophages, but also peritoneal fibroblasts, represent
key sources of chemokines, such as KC/CXCL1, MIP-2/CXCL2,
MCP-1/CCL2, RANTES/CCL5 and IP-10/CXCL10, upon
stimulation with cytokines, such as TNF-a, IL-1b and IFN-c.
These cells thus may provide endogenous chemokines in the
intraperitoneal environment [5,7,24,26,27]. Furthermore, neutro-
phils and other leukocytes also produce an array of chemokines,
including neutrophil chemotactic ELR+CXC chemokines and T
cell attracting chemokines MIG/CXL9, IP-10/CXCL10 and I-
TAC/CXCL11 [5,28], whereas endogenous MIP-2/CXCL2 may
originate from resident macrophages or other peritoneal cells [29].
We showed that COAM is a potent chemokine-binding
molecule and this fact may explain the observed in vivo cell
recruitment results. Consistently, we observed binding of COAM
to the neutrophil chemoattractants GCP-2/CXCL6, KC/CXCL1
and MIP-2/CXCL2. The affinities for GCP-2/CXCL6, KC/
CXCL1 and MIP-2/CXCL2 were in the nM-range and similar to
binding affinities determined for heparan sulphate. Similarly, IP-
10/CXCL10 was found to be a chemokine with high affinity for
COAM as well as for heparan sulphate, whereas the tested CC
chemokines RANTES/CCL5 and MIP-1a/CCL3, MIP-1b/
CCL4 or MCP-1/CCL2 displayed only weak or no binding.
Due to the negatively charged nature of GAGs and the highly
basic character of most chemokines (isoelectric points between pI
9–10, except for MIP-1a/CCL3 or MIP-1b/CCL4, see Table 5),
interactions between chemokines and GAGs were understood to
depend on non-selective electrostatic forces. However, the
discovery of distinct GAG-binding epitopes added a degree of
specificity to the level of regulation of chemokine action [11].
Mutations in GAG-binding sites of MCP-1/CCL2, MIP-1b/
CCL4 and RANTES/CCL5 disturb chemotactic activity in vivo.
However, chemotaxis in vitro is not affected. Moreover, the
formation of higher-order chemokines and their oligomerization
on GAGs is also pivotal for their in vivo function, further
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underlining the importance and absolute requirement of GAG
binding to chemokines in vivo [30]. The existence of differential
kinetics of chemokine-GAG interactions may be an important
mechanism by which distinct chemokine gradients are orchestrat-
ed in vivo. For instance, following KC/CXCL1 and MIP-2/
CXCL2 instillation in lungs, quantitative and temporal differences
in pulmonary neutrophil recruitment are based on differences in
association and dissociation rates of chemokines with heparan
sulphate [31]. Complementary to the suggested endogenous
chemokine-binding and –presenting functions of COAM, the
in vivo mechanism of action of COAM may also involve the
presentation of (inactive) matrix-bound chemokines or the
prolongation of the chemokine actions/half-lives.
Aside electrostatic forces, the presence of GAG-binding epitopes
on chemokines provides a certain degree of selectivity [11]. All
tested chemokines with theoretical pI values between 8.5 and 11
and containing 5 to 15 basic amino acids in their carboxyterminus
were found to bind COAM as well as heparan sulphate. The low
abundance of positively-charged amino acids in its carboxytermi-
nus together with a high C-terminal serine/threonine content
might explain why mouse MCP-1/CCL2 did not bind to COAM
or heparan sulphate. For clarity, human MCP-1/CXCL2 has
different biochemical characteristics than mouse MCP-1/CXCL2,
mainly by considerable differences at its carboxyterminus, the
supposed interaction site with COAM. For instance and in
comparison with the other studied mouse chemokines, mouse
MCP-1/CXCL2 contains only two basic amino acids in its
carboxyterminus (Table 5). This constitutes a plausible explana-
tion for differences in heparin sulphate (and COAM) binding of
human MCP-1/CXCL2 [32,33] versus mouse MCP-1/CXCL2
(this study). Likewise, the low theoretical pIs of MIP-1a/CCL3
and –b/CCL4, respectively 5.14 and 5.64, together with few basic
carboxy-terminal amino acids likely explain our negative chemo-
kine binding results for COAM and heparan sulphate. In view of
the chemical structure of COAM [19], chemokine binding to
COAM might protect these chemokines from proteolytic degra-
dation. Protection from proteolysis has been demonstrated in the
case of interaction between heparin and eotaxin [12] and between
heparan sulphate and IL-8 [34] or SDF-1 [35].
Soluble GAGs, in contrast to cell surface- or extracellular
matrix-associated GAGs, when forming complexes with chemo-
kines, inhibit chemokine receptor activation by competition for
chemokine binding, resulting in inhibition of leukocyte responses
[36,37]. In sharp contrast to these findings with heparin, our
results suggest that COAM, as a soluble molecule displaying GAG
mimetic properties, does not inhibit but instead stimulates
chemokine function by binding to chemokines, and in particular
potentiates neutrophil chemotaxis toward GCP-2/CXCL6 and
MIP-2/CXCL2 in vivo. COAM, by its high affinity for (neutro-
phil) chemokines might act like a sponge and bind local and
systemic chemokines in such a way that they retain their
chemotactic activity. In this way, the majority of leukocytes is
recruited to the COAM injection site and thus might displace
leukocytes from distant organs, as was here observed in the liver
tissue. Although alternative explanations are possible, we suggest
that COAM, by its repetitive structure, might bind and present
endogenous chemokines side-by-side in a multivalent way and
with the chemokine receptor-binding face exposed, in order to
support efficient cell recruitment. This recruitment phenomenon
by COAM is so potent that it also has systemic effects, as
previously shown on the central nervous system [17] and, in this
study, on the liver.
In conclusion, we have shown that the polysaccharide derivative
COAM formed a binding complex with chemokines, which in
turn influenced chemokine localization and selectivity of leukocyte
responses. As evidenced here in three in vivo models, binding of
chemokines to COAM affected neutrophil migration in vivo. The
insights obtained by this study about the relative binding selectivity
of COAM for specific chemokines may be exploited to redirect the
migration of specific leukocytes in vivo. In this way, COAM is an
interesting molecular probe for chemokine-mediated immuno-
modulation and stands as a first example of an effective GAG
mimetic, retaining chemotactic functionality of bound chemo-
kines.
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